GSE137056
Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
Doxorubicin Treated LNCaP cells RNA-sequencing, and AR and TBP Chromatin immunoprecipitation sequencing Overall design: LNCaP cells were charcoal strip serum androgen starved, then stimulated with 1nM R1881 and/or 0.1, 0.4, or 0.7 µM Doxorubicin.